|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Respiratory Medicine, Beaumont Hospital, Dublin, Ireland.
| Abstract |
|---|
|
|
|---|
Design: Fourteen patients with an acute exacerbation of COPD and a PaO2 < 64 mm Hg were studied. Initially, the patients breathed room air (hypoxemia). Then their arterial oxygen saturation was raised to approximately 95% (normoxemia) and then to 98 to 99% (hyperoxemia). Finally, 1 L/min of carbon dioxide was added to the circuit (hyperoxemic hypercapnia). Using duplex ultrasonography, the pulsatility index (PI) of an intrarenal artery was measured after 10 min at each level of oxygenation. The PI is an index of distal renovascular resistance.
Results: The PI fell significantly from room-air values on inducing hyperoxemia (p < 0.05). This suggests decreased renovascular resistance and increased renal blood flow. When hyperoxemic hypercapnia was induced, the PI rose significantly from the hyperoxemia level (p < 0.001).
Conclusions: In hypoxemic patients, renovascular resistance decreased when hyperoxemia was induced. This fall in renovascular resistance was reversed with the addition of carbon dioxide. This suggests that acute changes in carbon dioxide levels might have a more dominant role than oxygen levels in determining renovascular resistance.
Key Words: carbon dioxide COPD oxygen renal vascular resistance
| Introduction |
|---|
|
|
|---|
In this study, we investigated renal vascular resistance in a group of patients with hypoxemia secondary to COPD. We studied the effects of added oxygen and carbon dioxide on their renal vascular resistance, which we measured noninvasively using duplex ultrasonography. Changes in renal vascular resistance reflect alterations in renal vasoconstriction and thus, indirectly, in RBF. We postulated that improved oxygenation would decrease renal vascular resistance and that induced hypercapnia would have the opposite effect.
| Materials and Methods |
|---|
|
|
|---|
Renal Hemodynamics
All studies were performed at the same time each day. A
real-time ultrasound scanner (model 128XP; Acuson; Mountain View,
CA) with color flow and pulsed-scanning facility was used for
the Doppler ultrasound examinations.9
With the patient in
the seated position, the right kidney was scanned with a 2-MHz probe
via the translumbar route.8
10
A renal interlobar artery
was selected near the renal hilum. The angle of the ultrasound beam was
adjusted until the maximum Doppler frequency shift was obtained. From
the sonogram that was produced, the integrated computer software
(Graphpad Prism, version 2.0; Graphpad Software Inc; San Diego, CA)
calculated the pulsatility index (PI).11
The PI is an
index of resistance to flow distal to the point of sampling; therefore,
it is an indirect index of the degree of vasoconstriction, rather than
a direct measurement of RBF. The lower the PI, the less the resistance
to flow and, therefore, the greater the rate of flow. The PI results
presented are each the mean of three measurements.
Validation
The PI has been validated in healthy volunteers.12
Using dopamine and dobutamine to vary renovascular resistance, the
changes in renal vascular resistance, as measured using classical
methodology,12
correlated strongly with changes in the PI.
A further study13
showed that both the PI and resistive
index correlated significantly with effective renal plasma flow, renal
vascular resistance, filtration fraction, and creatinine clearance. In
a study of renal hemodynamics in COPD, the PI and the mean of the
maximum instantaneous flow were used.8
All of the subjects
increased their mean of the maximum instantaneous flow and had a
simultaneous decrease in their PI in response to inhaled oxygen,
suggesting that both parameters are equally sensitive to changes in
renal hemodynamics in COPD. In our center, the coefficient of variation
of PI is 2.05%.9
14
Circuit
A circuit incorporating a two-way tap was constructed, allowing
the patient to breathe room air to which oxygen and carbon dioxide at
varying flow rates could be added. The patient breathed through a
one-way valve attached to a tightly fitting face mask. The arterial
oxygen saturation (SaO2) was
monitored by means of a pulse oximeter with an ear probe (Critikon
Oxyshuttle; SensorMedics; Anaheim, CA). End-tidal
CO2 (ETCO2) was monitored
by a capnometer (model M1016A; Hewlett Packard; Waltham, MA),
with the carbon dioxide sensor attached to the expiratory port. The
capnometer was calibrated before each study, and air leaks were
excluded with the device in use. We measured
ETCO2 rather than transcutaneous carbon dioxide
levels because transcutaneous measurements take longer to equilibrate.
The gradient between PaCO2 and
ETCO2 is usually small (< -5.25 mm
Hg) in normal subjects. We accept that
ETCO2 measurements may not be accurate in
patients with pulmonary disease, especially COPD,15
as
such patients have an uneven distribution of ventilation and the
arterial/ETCO2 gradient widens from 9.8 to 20.3
mm Hg.16
However, we were not concerned with the absolute
values of ETCO2, but rather we wished to monitor
changing trends in ETCO2 with the addition of
oxygen and carbon dioxide.
Our aim was to study the renal vascular resistance in each patient at standardized levels of SaO2 and ETCO2. Each patient was studied at baseline (room air), and then with an SaO2 of approximately 95% (normoxemia), and then 98 to 99% (hyperoxemia). The fraction of inspired oxygen was titrated in each case to achieve the desired SaO2. Each level of SaO2 was maintained for at least 10 min after stabilization, and the renal vascular resistance was remeasured. There were no intervening rest periods. After 10 min of hyperoxemia, 1 L/min of carbon dioxide was added to the circuit for 10 min, or until the ETCO2 stabilized, and the renal vascular resistance was remeasured. We aimed to achieve an increase in the ETCO2 level of approximately 15 mm Hg from the hyperoxemic value. We used a 10-min period of exposure to the different gas inhalations because a pilot study found that more prolonged exposure in similar patients resulted in respiratory distress and dizziness. We recorded both the pulse rate and the arterial BP throughout the study.
Data Analysis
The PI measurements during the inhalation of different gas
mixtures were compared using the Kruskal-Wallis test for nonparametric
data. The Dunn multiple comparison test was used, where appropriate, to
determine the levels at which the changes in PI were significant.
Numeric variables were compared between the different subgroups by the
Mann-Whitney test for nonparametric data. Variables were also compared
by means of least squares regression analysis. The results are given as
mean (± SD), and p < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
|
Ten patients had a room-air PaCO2 > 45 mm Hg, and we compared these patients to the patients without hypercapnia. Contrary to our expectations, the room-air PI was similar for the hypercapnia group and the normocapnia group, respectively:1.14 ± 0.15 vs 1.20 ± 0.11. The baseline SaO2 was similar for the hypercapnia group and the normocapnia group, respectively: 87.7 ± 4.7% vs 88.3 ± 5.7%. The difference in ETCO2 between the hypercapnia group and the normocapnia group was significant: 35.0 ± 4.1 vs 27.7 ± 2.1 mm Hg, respectively (p < 0.05). There was no significant difference between the hypercapnia and normocapnia patients in their PI responses to variations in inspired gases. We also found similar mean PI results when comparing patients with edema to patients without edema, respectively: 1.10 ± 0.15 vs 1.08 ± 0.18 (not significant). There was no significant change in the pulse rate and BP at the various stages of the study.
| Discussion |
|---|
|
|
|---|
Studies carried out on COPD patients during an acute exacerbation have shown decreased RBF in the presence of hypercapnia.4 6 7 The most recent of these studies7 showed that COPD patients with hypercapnic respiratory failure had a lower RBF than the normocapnic, hypoxemic patients. However, in the current study, as in one of our previous studies,9 we found no significant difference between the baseline RBF of our normocapnic and hypercapnic subjects. A possible explanation for the discrepancy in these findings is that while the level of hypercapnia was similar in both this study and that of Howes et al,7 our hypercapnic subjects were slightly less hypoxemic than the subjects of Howes et al. However, all of our subjects, whether normocapnic or hypercapnic at baseline, had a rapid and marked rise in renovascular resistance when they inhaled additional carbon dioxide. These findings support a differential renal hemodynamic response to acute and chronic hypercapnia. Chronic hypercapnia, unlike acute hypercapnia, is associated with changes in hydrogen ion concentration, and this may play a role in influencing renal hemodynamics. While an animal study17 has shown that the reduction in RBF with hypercapnia is independent of the hydrogen ion concentration, to our knowledge, there are no equivalent human studies.
Hypercapnia can influence renal hemodynamics by direct and indirect mechanisms. Hypercapnia can cause direct renal vasoconstriction,5 and hypercapnia also stimulates noradrenaline release by direct action on the sympathetic nervous system.18 Indirectly, hypercapnia causes systemic vasodilation, inactivating the baroreceptors with a subsequent release of noradrenaline, leading to a fall in RBF.1 2 18 Neurogenic control of RBF in response to hypercapnia may also be important, as an animal study17 has shown that this response is abolished by renal denervation.
The effect of hypoxemia on renal hemodynamics is less clear. The majority of previous studies6 7 8 on COPD patients showed decreased RBF in the presence of hypoxemia. In an early study, RBF increased in response to moderate hypoxemia, and it was only in the presence of severe hypoxemia (a PaO2 < 40 mm Hg) that RBF decreased.6 Recent studies7 8 of COPD patients with moderate hypoxemia have found reduced RBF. Our study supports these findings, as our patients (with comparable hypoxemia) also had decreased renovascular resistance with improved oxygenation, although this only reached significance when the SaO2 reached 98 to 99%. It is possible that our patients could have had a significant improvement in PI if the SaO2 had been maintained at 95% for > 10 min.
The mechanism whereby hypoxemia affects renal hemodynamics is not fully understood. In animal studies, changes in RBF secondary to hypoxemia are abolished by the denervation of the peripheral chemoreceptors, and are attenuated by renal denervation but not influenced by adrenalectomy.19 This suggests that changes in RBF are caused by a reflex mechanism that is dependent on the sympathetic afferent nerves to the kidney and chemoreceptor stimulation. We previously studied14 a group of normal and renal transplant subjects (with denervated kidneys) and measured their renal vascular resistance in response to hypoxemia. We found that renal denervation does not completely abolish the renovascular responses to hypoxemia.14 Nitric oxide (NO) may also have a role in the renal hemodynamic response to hypoxemia. Howes et al20 found that hypoxemic COPD patients were unresponsive to L-arginine, a NO precursor, while L-arginine caused renal vasodilatation in normal subjects; therefore, the researchers concluded that the disturbance in renovascular tone seen in hypoxemic COPD patients may be due to a disturbance of the NO pathway.
Clinical experience suggests that renal function in COPD patients improves with increased oxygenation. We investigated the effect of hyperoxemia on renal hemodynamics to determine whether maximum vasodilatation occurred at physiologic levels of oxygenation (a SaO2 of 95%), or whether further vasodilatation occurred with hyperoxemia. We found that the maximum renal vasodilatation occurred during hyperoxemia. The mechanism whereby hyperoxemia influences renal hemodynamics is unknown, but it may be due to inhibition of the chemoreceptors by hyperoxemia. Contrary to our expectations, in this study, the ETCO2 did not rise with increasing levels of inhaled oxygen. A possible explanation for the failure of ETCO2 to rise might be that the duration of hyperoxemia was too short to allow the ETCO2 levels to increase.
In summary, we found that in patients with hypoxemia, renovascular resistance decreased when hyperoxemia was induced. This improvement in renovascular resistance was reversed by elevating carbon dioxide levels, suggesting that acute changes in carbon dioxide may play a more dominant role than oxygen in determining RBF. This emphasizes the importance of controlled oxygen therapy and the prevention of progressive hypercapnia in patients with an acute exacerbation of COPD.
| Footnotes |
|---|
Abbreviations: ETCO2 = end-tidal CO2; NO = nitric oxide; PI = pulsatility index; RBF = renal blood flow; SaO2 = arterial oxygen saturation
Received for publication June 26, 1998. Accepted for publication January 6, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B Schonhofer, T Barchfeld, M Wenzel, and D Kohler Long term effects of non-invasive mechanical ventilation on pulmonary haemodynamics in patients with chronic respiratory failure Thorax, July 1, 2001; 56(7): 524 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
P M Turkington and M W Elliott Rationale for the use of non-invasive ventilation in chronic ventilatory failure Thorax, May 1, 2000; 55(5): 417 - 423. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |